The Epstein-Barr virus (EBV)-induced tumor suppressor microrna MiR-34a is growth promoting in EBV-infected B cells

Journal of Virology

Volumn 86, Issue 12, 2012, Pages 6889-6898

  Forte, Eleonora ^a,c   Salinas, Raul E ^a   Chang, Christina ^a   Zhou, Ting ^a   Linnstaedt, Sarah D ^a   Gottwein, Eva ^a,c   Jacobs, Cassandra ^a   Jima, Dereje ^b   Li, Qi Jing ^a   Dave, Sandeep S ^b   Luftig, Micah A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LATENT MEMBRANE PROTEIN 1; MICRORNA 34A; MYC PROTEIN; PROTEIN P53;

ARTICLE; B LYMPHOCYTE; CELL GROWTH; CELL IMMORTALIZATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS INFECTION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INACTIVATION; GENE OVEREXPRESSION; GENE REPRESSION; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE TRANSFORMATION; MOLECULAR DYNAMICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; UPREGULATION; VIRUS CELL INTERACTION;

B-LYMPHOCYTES; CELL LINE, TUMOR; CELL PROLIFERATION; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; MICRORNAS; NF-KAPPA B; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 8;

EID: 84863993239     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.07056-11     Document Type: Article

References (49)

1. Cameron JE, et al. 2008. Epstein-Barr virus growth/latency III program alters cellular microRNA expression. Virology 382:257-266.
2. Cameron JE, et al. 2008. Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways. J. Virol. 82:1946 -1958.
3. Chang TC, et al. 2007. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell 26:745-752.
4. Christoffersen NR, et al. 2010. p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC. Cell Death Differ. 17:236 -245.
5. DE Oliveira DE, Ballon G, Cesarman E. 2010. NF-kappaB signaling modulation by EBV and KSHV. Trends Microbiol. 18:248 -257.
6. Devergne O, et al. 1996. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation. Mol. Cell. Biol. 16:7098 -7108.
7. Dull T, et al. 1998. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72:8463- 8471.
8. Ebert MS, Neilson JR, Sharp PA. 2007. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Methods 4:721-726.
9. Farrell PJ, Allan GJ, Shanahan F, Vousden KH, Crook T. 1991. p53 is frequently mutated in Burkitt's lymphoma cell lines. EMBO J. 10:2879- 2887.
10. Faumont N, et al. 2009. c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells. J. Virol. 83:5014 -5027.
11. Gao P, et al. 2009. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458:762- 765.
12. Garzon R, Calin GA, Croce CM. 2009. MicroRNAs in cancer. Annu. Rev. Med. 60:167-179.
13. Gatto G, et al. 2008. Epstein-Barr virus latent membrane protein 1 transactivates miR-155 transcription through the NF-kappaB pathway. Nucleic Acids Res. 36:6608-6619.
14. Godshalk SE, Bhaduri-McIntosh S, Slack FJ. 2008. Epstein-Barr virusmediated dysregulation of human microRNA expression. Cell Cycle 7:3595-3600.
15. Gottwein E, Cai X, Cullen BR. 2006. A novel assay for viral microRNA function identifies a single nucleotide polymorphism that affects Drosha processing. J. Virol. 80:5321-5326.
16. Gottwein E, Cullen BR. 2010. A human herpesvirus microRNA inhibits p21 expression and attenuates p21-mediated cell cycle arrest. J. Virol. 84:5229 -5237.
17. Gottwein E, et al. 2007. A viral microRNA functions as an orthologue of cellular miR-155. Nature 450:1096 -1099.
18. Guasparri I, Bubman D, Cesarman E. 2008. EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression. Blood 111:3813-3820.
19. Hashimi ST, et al. 2009. MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation. Blood 114:404-414.
20. He L, et al. 2007. A microRNA component of the p53 tumour suppressor network. Nature 447:1130 -1134.
21. Iorio MV, Croce CM. 2009. MicroRNAs in cancer: small molecules with a huge impact. J. Clin. Oncol. 27:5848 -5856.
22. Izumi KM, Kieff ED. 1997. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptorassociated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB. Proc. Natl. Acad. Sci. U. S. A. 94: 12592-12597.
23. Jiang J, Lee EJ, Schmittgen TD. 2006. Increased expression of microRNA-155 in Epstein-Barr virus transformed lymphoblastoid cell lines. Genes Chromosomes Cancer 45:103-106.
24. Kieff E, Rickinson A. 2007. Epstein-Barr virus and its replication, p 2603-2654. In Knipe DM, Howley PM (ed), Fields virology, 5 ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
25. Lawrie CH, et al. 2008. MicroRNA expression in lymphocyte development and malignancy. Leukemia 22:1440 -1446.
26. Linnstaedt SD, Gottwein E, Skalsky RL, Luftig MA, Cullen BR. 2010. Virally induced cellular miR-155 plays a key role in B-cell immortalization by EBV. J. Virol. 84:11670 -11678.
27. Lu F, et al. 2008. Epstein-Barr virus-induced miR-155 attenuates NFkappaB signaling and stabilizes latent virus persistence. J. Virol. 82:10436- 10443.
28. Motsch N, Pfuhl T, Mrazek J, Barth S, Grasser FA. 2007. Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a. RNA Biol. 4:131-137.
29. Mrazek J, Kreutmayer SB, Grasser FA, Polacek N, Huttenhofer A. 2007. Subtractive hybridization identifies novel differentially expressed ncRNA species in EBV-infected human B cells. Nucleic Acids Res. 35:e73. doi: 10.1093/nar/gkm244.
30. Mu P, et al. 2009. Genetic dissection of the miR-17 92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev. 23:2806 - 2811.
31. Navarro F, et al. 2009. miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53. Blood 114:2181-2192.
32. Nikitin PA, et al. 2010. An ATM/Chk2-mediated DNA damageresponsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cells. Cell Host Microbe 8:510 -522.
33. Njie R, et al. 2009. The effects of acute malaria on Epstein-Barr virus (EBV) load and EBV-specific T cell immunity in Gambian children. J. Infect. Dis. 199:31-38.
34. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. 2005. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839-843.
35. Pang RT, et al. 2010. MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells. Carcinogenesis 31:1037-1044.
36. Petrocca F, Vecchione A, Croce CM. 2008. Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res. 68:8191- 8194.
37. Rahadiani N, Takakuwa T, Tresnasari K, Morii E, Aozasa K. 2008. Latent membrane protein-1 of Epstein-Barr virus induces the expression of B-cell integration cluster, a precursor form of microRNA-155, in B lymphoma cell lines. Biochem. Biophys. Res. Commun. 377:579 -583.
38. Ranganath S, et al. 1998. GATA-3-dependent enhancer activity in IL-4 gene regulation. J. Immunol. 161:3822-3826.
39. Raver-Shapira N, et al. 2007. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol. Cell 26:731-743.
40. Sullivan CS, Cullen BR. 2009. Non-coding regulatory RNAs of the DNA tumor viruses, p 645-682. In Damania B, Pipas J (ed), DNA Tumor Viruses. Springer, New York, NY.
41. Sun F, et al. 2008. Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett. 582:1564 -1568.
42. Tarasov V, et al. 2007. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6:1586 -1593.
43. Tazawa H, Tsuchiya N, Izumiya M, Nakagama H. 2007. Tumorsuppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc. Natl. Acad. Sci. U. S. A. 104:15472-15477.
44. Tusher VG, Tibshirani R, Chu G. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U. S. A. 98:5116 -5121.
45. Welch C, Chen Y, Stallings RL. 2007. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 26:5017-5022.
46. Yin Q, et al. 2008. MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways. J. Virol. 82:5295-5306.
47. Zhang J, et al. 2009. Patterns of microRNA expression characterize stages of human B cell differentiation. Blood 113:4586-4594.
48. Zhao B, et al. 2006. RNAs induced by Epstein-Barr virus nuclear antigen 2 in lymphoblastoid cell lines. Proc. Natl. Acad. Sci. U. S. A. 103:1900- 1905.
49. Zweidler-McKay PA, et al. 2005. Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies. Blood 106:3898 -3906.